Search - tctmd.com

Displaying 41 - 54 of 54

Sort: Relevancy | Date

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Conference News ACC 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

L.A. McKeown

March 18, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News STS 2019

No ‘July Effect’ Observed in Cardiac Surgery

Yael L. Maxwell

February 05, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Shelley Wood

January 04, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Vinay Badhwar About the STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the United States

September 27, 2019

CME

Advertisement

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

No ‘July Effect’ Observed in Cardiac Surgery

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Dr. C. Michael Gibson Talks With Dr. Vinay Badhwar About the STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the United States

Recent TAVR Updates and Upcoming Studies at ACC 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content